Blood substitute based on hemoglobin

Claim 2

A composition useful as a blood substitute or blood extender for administration to human or animal patients, said composition comprising the water soluble high molecular weight product of covalently coupling hemoglobin and a modified polysaccharide having a molecular weight of from about 5,000 to about 2,000,000, the modified polysaccharide being selected from the group consisting of dextran and hydroxyethyl starch modified to contain chemical groups capable of reaction with the chemical side groupings on the hemoglobin, said chemical side groupings being selected from the group consisting of amino, phenolic, sulfhydryl, thiomethyl, imidazo and carboxyl groupings.

Claim 3

The composition of claim 1 wherein the polysaccharide has a molecular weight of from about 5,000 to about 200,000.

Claim 4

The composition of claim 1 wherein the polysaccharide has a molecular weight of from about 20,000 to about 70,000.

Claim 5

The composition of claim 1 wherein the polysaccharide is dextran.

Claim 6

The composition of claim 4 which comprises the product of reacting hemoglobin with dextran modified to contain at least one chemical group reactive with a side grouping on the homoglobin and selected from the group consisting of acylating groups; alkylating groups; ester and amide forming groups; and disulfid forming groups.

Claim 7

The composition of claim 4 which comprises the product of reacting hemoglobin with dextran modified to contain at least one chemical group selected from the group consisting of dicarbonyl groups, diazo groups, and reactive groups from reaction of cyanogen bromide with the dextran.

Claim 8

The composition of claim 1 comprising the high molecular weight product of reacting bromoacetyl-aminoethyl-isoureido-polysaccharide with hemoglobin.

Claim 9

The composition of claim 1 comprising the high molecular weight product of reacting bromoacetyl-aminoethyl-O-polysaccharide with hemoglobin.

Claim 10

The composition of claim 1 comprising the high molecular weight product of reacting dialdehyde polysaccharide with hemoglobin.

Claim 11

A process for preparing a composition useful as a blood substitute or blood extender, which comprises: a. chemically modifying a polysaccharide of approximate molecular weight 5,000 - 2,000,000 and selected from the group consisting of dextran and hydroxyethyl starch, to introduce into said polysaccharide chemical groups capable of reaction with hemoglobin and selected from acylating groups, alkylating groups, ester forming groups, amide forming groups and disulfide forming groups; b. reacting the high molecular weight product of step (a) with hemoglobin, to form a water soluble covalently coupled complex thereof; the polysaccharide being selected from the group consisting of dextran and hydroxyethyl starch.

Claim 12

A process for preparing a composition useful as a blood substitute or blood extender, which comprises: a. chemically modifying a polysaccharide of approximate molecular weight 5,000 - 2,000,000 and selected from the group consisting of dextran and hydroxyethyl starch, to introduce into said polysaccharide chemical groups capable of reaction with hemoglobin and selected from acylating groups, alkylating groups, ester forming groups, amide forming groups and disulfide forming groups; b. reacting the high molecular weight product of step (a) with hemoglobin, to form a water soluble covalently coupled complex thereof; the polysaccharide being selected from the group consisting of dextran and hydroxyethyl starch.

Claim 13

The process of claim 10 which comprises the steps of: a. reacting the dextran or hydroxyethyl starch with cyanogen bromide; b. reacting the high molecular weight product of step (a) with diaminoethane; c. acylating the high molecular weight product of step (b) with a haloacetylhalide; d. reacting the high molecular weight product of step (c) with hemoglobin.

Claim 14

The process of claim 10 which comprises the steps of: a. reacting the dextran or hydroxyethyl starch with a 2-haloethylamine; b. reacting the high molecular weight product of step (a) with a haloacetylhalide; c. reacting the high molecular weight product of step (b) with hemoglobin.

Claim 15

A macromolecular water soluble compound having oxygen transporting capability and useful in blood substitute or blood extender composition, having an approximate molecular weight of from about 70,000 to about 2,000,000, and having the general formula (PS) -- X -- (HB), where (PS) represents a polysaccharide of molecular weight from about 5,000 to about 2,000,000 and selected from the group consisting of dextran and hydroxyethyl starch; X represents a covalently bonded chemical bridging group and Hb represents hemoglobin.

Claim 16

A macromolecular water soluble compound having oxygen transporting capability and useful in blood substitute or blood extender composition, having an approximate molecular weight of from about 70,000 to about 2,000,000, and having the general formula (PS) -- X -- (HB), where (PS) represents a polysaccharide of molecular weight from about 5,000 to about 2,000,000 and selected from the group consisting of dextran and hydroxyethyl starch; X represents a covalently bonded chemical bridging group and Hb represents hemoglobin.

Claim 17

The compound of claim 13, which is selected from the group consisting of hemoglobin-S-acetylaminoethyl-isoureido-polysaccharide; Hemoglobin-S-acetylaminoethyl-O-polysaccharide; and hemoglobin-N-dextran.